HTHirofumi Tsujino

Hirofumi Tsujino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hirofumi Tsujino has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A large pocket structure surrounding the catalytic center in the BCG protein from Mycobacterium tuberculosis

    by Kohei Takeshita, Naoki Sakai, Go Ueno, Midori Horie, Hirofumi Tsujino, Mitsuhiro Arisawa, Masaki Yamamoto, Masayoshi Arai, Taku Yamashita

    The widespread prevalence of tuberculosis and the need for extensive chemotherapy in its treatment are caused by the ability of tuberculosis (TB) bacteria to enter a dormant state. Therefore, it is crucial to develop effective compounds that can inhibit the growth of TB bacteria in both the active and dormant states. Previous research has identified agelasine D (marine sponge-derived diterpene alkaloid) capable of resisting dormant mycobacteria. Additionally, BCG3185c has been designated as a target mycobacterial protein. In this study, the crystal structure of BCG3185c was determined at a resolution of 1.86 Å. Analysis of this crystal structure revealed a large pocket toward the catalytic center of BCG3185c, which is potentially adequate for agelasine D binding. Based on the results of the interaction analysis between agelasine D and Bacillus Calmette-Guérin (BCG) proteins, it was inferred that the binding of agelasine D to this large pocket is crucial for suppressing the growth of Mycobacterium tuberculosis .

  • Open Access

    Silica Particles with Human Protein Corona Shows Sensitization Potential in the Human Cell Line Activation Test

    by Shun-Ichi Eto, Aoi Koshida, Hirofumi Tsujino, Kazuya Nagano, Kazuma Higashisaka, Yasuo Tsutsumi

    Nanoparticles are concerned to show adverse biological effects despite their unique functions. Their physicochemical properties and status are widely diverse; this makes safety analysis of nanoparticles complicated. Some reports showed that nanoparticles could disturb acquired immunity, while it is still unclear what is the inducer of that effects. Here, we tried to explore the relationship among nanoparticles’ physicochemical properties and sensitizing potential by using the human cell line activation test based in vitro method; that uses in expression of CD86 and CD54 as an index of cellular activation. As a model of nanoparticles, we examined sensitization potential of silica particles with or without a human protein corona. Of the cells treated with silica particles (diameter: 50 or 300 nm) only, none of them showed activation. On the other hand, silica particles with human protein corona showed activation. Moreover, protein corona that forms around 50 nm silica nanoparticles have a higher sensitization potential than that of protein corona that forms around 300 nm silica particles. Our findings indicated that silica particles with human protein corona showed sensitization potential, and that sensitization potential could depend on the amount or kind of proteins within the corona.


  • One-pot enyne metathesis/Diels–Alder/oxidation to six-membered silacycles with a multi-ring core: discovery of novel fluorophores

    by Shohei Yoshioka, Yuki Fujii, Hirofumi Tsujino, Tadayuki Uno, Hiromichi Fujioka, Mitsuhiro Arisawa

    One-pot enyne metathesis/Diels–Alder/oxidation methodology was developed to give fluorescent six-membered silacycle with multi-ring core.


  • Open Access

    Membrane Anchor of Cytochrome P450 Reductase Suppresses the Uncoupling of Cytochrome P450

    by Masayoshi Miyamoto, Taku Yamashita, Yuki Yasuhara, Akinori Hayasaki, Yukari Hosokawa, Hirofumi Tsujino, Tadayuki Uno

    Cytochrome P450 reductase (CPR) is an important redox partner of microsomal CYPs. CPR is composed of a membrane anchor and a catalytic domain that contains FAD and flavin mononucleotide (FMN) as redox centers and mediates electron transfer to CYP. Although the CPR membrane anchor is believed to be requisite for interaction with CYP, its physiological role is still controversial. To clarify the role of the anchor, we constructed a mutant (Δ60-CPR) in which the N-terminal membrane anchor was truncated, and studied its effect on binding properties, electron transfer to CYP2C19, and drug metabolism. We found that Δ60-CPR could bind to and transfer electrons to CYP2C19 as efficiently as WT-CPR, even in the absence of lipid membrane. In accordance with this, Δ60-CPR could mediate metabolism of amitriptyline (AMT) and imipramine (IMP) in the absence of lipids, although activity was diminished. However, Δ60-CPR failed to metabolize omeprazole (OPZ) and lansoprazole (LPZ). To clarify the reason for this discrepancy in drug metabolism, we investigated the uncoupling reaction of the CYP catalytic cycle. By measuring the amount of H2O2 by-product, we found that shunt pathways were markedly activated in the presence of OPZ/LPZ in the Δ60-CPR mutant. Because H2O2 levels varied among the drugs, we conclude that the proton network in the distal pocket of CYP2C19 is perturbed differently by different drugs, and activated oxygen is degraded to become H2O2. Therefore, we propose a novel role for the membrane anchor as a suppressor of the uncoupling reaction in drug metabolism by CYP.